Article
B&L wins FDA review, kicks off celebration
Rochester, NY-Bausch &Lomb is looking to the future and the past as it celebrates the FDA acceptance of a new drug application for its new anti-inflammatory/antibiotic combination product while marking the company's 150 years in business.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
